VANGUARD GROUP INC 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 1:55 pm Sale | 2026-03-13 | 13G | VIR BIOTECHNOLOGY INC VIR | VANGUARD GROUP INC | 0 0.000% | -12,297,139 (Position Closed) | Filing |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | VIR BIOTECHNOLOGY INC VIR | VANGUARD GROUP INC | 12,297,139 9.140% | 2,202,638 (+21.82%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | VIR BIOTECHNOLOGY INC VIR | VANGUARD GROUP INC | 10,094,501 7.580% | 2,764,370 (+37.71%) | Filing |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | VANGUARD GROUP INC | 7,330,131 5.600% | 7,330,131 (New Position) | Filing |